China Solar Additions Surge to Record in May Ahead of Deadline
The country installed 93 gigawatts of panels last month, according to data released by the National Energy Administration, four times more than in the same period in 2024. The previous record was 71 gigawatts in December. The May figure means China installed more solar capacity in a single month than any other country did in all of 2024, according to BloombergNEF data.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Brewing Innovation: Univers and Starbucks China Redefine Green Retail from Store to Supplier
SINGAPORE, July 29, 2025 /PRNewswire/ -- Univers, the global AI for Energy leader, and Starbucks China have unveiled a technological partnership to accelerate sustainability across Starbucks' China value chain. Through the deployment of Univers' advanced AI and Internet of Things (IoT) decarbonization solutions, the collaboration will enable Starbucks to digitally monitor, measure and actively reduce Scope 3 emissions across its supplier network. This visibility will allow Starbucks to drive actionable emissions reductions, support its suppliers in their own low-carbon transitions, and strengthen compliance with evolving climate regulations. Greener Store Starbucks is not only making their stores greener, but also more intelligent. More than 7,500 Starbucks stores are now connected to a new AI and IoT platform jointly developed by Univers and Starbucks. This will enable real-time and remote monitoring of over 8 types of equipment per store including HVAC, lighting, and water filtration, optimizing energy use with AI-driven insights and enhancing partner and customer experience. Greener Supply Chain Leveraging Univers' EnOSTM Ark Carbon Management System, Univers and Starbucks will develop a Supply Chain Carbon Management Platform used to track carbon emissions across core suppliers and products—including but not limited to milk, beverages, food, and packaging. Milk, the single largest carbon emitter in Starbucks value chain, is a major contributor to Scope 3 emissions. As a response, the companies developed a Sustainable Dairy Digital Management Tool to enable comprehensive carbon baseline tracking, decarbonization planning, and implementation of pilot farm solutions. Future-Proofing Starbucks With Univers' global innovative R&D capabilities in AI and IoT, Starbucks can now meet its future business expansion needs with the next-generation edge computing intelligent device One-Box, which integrates computing power and hardware management across five local application scenarios from point-of-sale systems to smart store control terminals. By embedding Univers' EnOSTM Ark Carbon Management platform into its broader sustainability strategy, Starbucks is taking a major step toward future proofing its energy transition journey – combining technology, data and cross-sector collaboration to set new standards for decarbonization in the food and beverage retail industry. About Univers Univers is a global leader in AI for Energy. Our EnOSTM platform enables enterprises to solve complex energy challenges through intelligent, data-driven insights. With 365 million connected devices and 845 GW of renewable energy managed, Univers is an AI-native company delivering end-to-end energy management solutions that support organizations across every stage of their energy transition journey For more information, please visit View original content: SOURCE Univers Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Canara HSBC Life Insurance Launches SecureInvest- A Unit-linked Plan Offering Life Cover up to 100x of Annualised Premium
SecureInvest Rewards Long-Term Commitment with Loyalty Additions and Maturity BoostersTailored for Every Life Stage: Choose Between SecureInvest Choice Option and SecureInvest Forever Option NEW DELHI, July 29, 2025 /PRNewswire/ -- Canara HSBC Life Insurance Company Limited ('Canara HSBC Life Insurance'), today announced the launch of its latest product 'SecureInvest,' (UIN: 136L092V01) a non-participating, Unit Linked Individual Life Insurance Savings Plan designed to align with the evolving financial goals and life stages of policyholders. SecureInvest combines high life cover offering up to 100 times of the Annualized Premium with the potential for market-linked growth. Speaking on the launch, Mr. Rishi Mathur, Chief Distribution Officer- Alternate Channels and Chief Marketing Officer, Canara HSBC Life Insurance said, "At Canara HSBC Life Insurance, we understand that life is full of promises, to grow, to protect, and to leave a legacy. To ensure these promises are met, we have crafted this plan tailored to every stage of the policyholder's life. SecureInvest reflects our continued focus on creating meaningful solutions for our customers. This plan blends substantial life cover, investment growth, and long-term value creation- all in one offering designed to evolve with the customer's financial journey." This plan is packed with consumer-friendly features. Policyholders are rewarded for their long-term commitment with Loyalty Additions starting at the end of the 10th policy year and recurring every 5th year thereafter, along with Maturity Boosters at the end of the policy term. Policyholders may also benefit from tax advantages on premiums paid and benefits received, as per prevailing tax laws. SecureInvest comes with two plan options, catering to different life goals: SecureInvest Choice– Offers life cover during the policy term, plus the accumulated fund value on maturity. SecureInvest Forever – Extends protection up to age 85, making it ideal for those who wish to build a legacy for their loved ones. The plan also includes 12 fund choices, six portfolio management strategies, and features like partial withdrawals, premium redirection, and fund switching offering policyholders' greater control over their investments. About Canara HSBC Life Insurance: Incorporated in 2007, Canara HSBC Life Insurance Company Limited is promoted by Canara Bank and HSBC Insurance (Asia Pacific) Holdings Limited. Punjab National Bank is also a shareholder of the Company. As a bancassurance led insurance company with its corporate office at Gurugram, Haryana and more than 100 branch offices as of the date of the DRHP (defined below), pan India, Canara HSBC Life brings together the trust and market knowledge of public and private banks. For more than 17 years now, the Company sells and services customers through multiple channels and well diversified network of Canara Bank and the Indian branch of the Hongkong and Shanghai Banking Corporation Limited in multiple cities across the country. The Company has a vast portfolio of life insurance solutions and offers various products across individual and group space comprising of life, health, term plans, retirement solutions, credit life and employee benefit segments through partner banks, digital, and direct field force. With an aim to provide simpler insurance and faster claim process, the Company intends to keep the promises of their customers alive with their 'Promises Ka Partner' philosophy. Canara HSBC Life Insurance Company Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offering of its equity shares and has filed a draft red herring prospectus dated April 28, 2025 ("DRHP") with the Securities and Exchange Board of India ("SEBI"). The DRHP is available on the website of the Company at the SEBI at the website of National Stock Exchange of India Limited at and the website of BSE Limited at and the respective websites of the Lead Managers at and Investors should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the RHP which may be filed with the Registrar of Companies, Delhi and Haryana at New Delhi, in the future, including the section titled "Risk Factors". Potential investors should not rely on the DRHP filed with the SEBI, but should instead rely only on the RHP, in making any investment decision. The equity shares proposed to be offered in the initial public offering may not be offered or sold in the United States except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the U.S. Securities Act of 1933, as amended. There will be no public offer of securities in the United States. Logo: View original content to download multimedia:
Yahoo
31 minutes ago
- Yahoo
Undiscovered Gems in Asia for July 2025
Amidst a backdrop of mixed performances in global indices, with the small-cap Russell 2000 showing positive movement while other midcap indices falter, the Asian markets are offering intriguing opportunities for discerning investors. In this dynamic environment, identifying stocks that demonstrate resilience and potential for growth becomes essential, particularly those that can navigate economic shifts and capitalize on regional strengths. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating Ampire NA -2.21% 8.00% ★★★★★★ Orient Pharma 17.16% 26.65% 68.11% ★★★★★★ Oriental Precision & EngineeringLtd 39.11% 5.91% 0.76% ★★★★★☆ E J Holdings 21.62% 4.30% 3.77% ★★★★★☆ Tokyo Tekko 8.47% 8.06% 24.39% ★★★★★☆ Zhejiang Jinghua Laser TechnologyLtd 2.85% 4.02% -2.43% ★★★★★☆ Uju Holding 33.18% 8.01% -15.93% ★★★★★☆ Iljin DiamondLtd 2.55% -3.23% 0.91% ★★★★☆☆ Shenzhen Leaguer 63.12% 1.96% -16.52% ★★★★☆☆ ASRock Rack Incorporation 77.35% 311.61% 693.05% ★★★★☆☆ Click here to see the full list of 2605 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. We're going to check out a few of the best picks from our screener tool. Alphamab Oncology Simply Wall St Value Rating: ★★★★★☆ Overview: Alphamab Oncology is a clinical stage biopharmaceutical company focused on the research, development, manufacture, and commercialization of oncology biologics with a market cap of HK$9.03 billion. Operations: The company generates revenue primarily from its pharmaceuticals segment, amounting to CN¥640.08 million. Alphamab Oncology, a small player in the biotech space, has turned profitable this year and is trading at 77.8% below its estimated fair value. Despite a volatile share price recently, the company shows promise with its innovative treatments like JSKN003 for advanced tumors and KN026 for HER2-positive cancers. The debt to equity ratio slightly rose from 9.5 to 9.9 over five years, but it still holds more cash than total debt, indicating financial stability. Recent executive changes bring experienced leadership on board as Alphamab positions itself for future growth in the competitive biotech industry. Click here to discover the nuances of Alphamab Oncology with our detailed analytical health report. Review our historical performance report to gain insights into Alphamab Oncology's's past performance. Guangdong Orient Zirconic Ind Sci & TechLtd Simply Wall St Value Rating: ★★★★★☆ Overview: Guangdong Orient Zirconic Ind Sci & Tech Co., Ltd focuses on the research, development, production, and sale of zirconium products with a market capitalization of CN¥10.61 billion. Operations: The company generates revenue primarily from producing and selling titanium ore, zirconium series products, and structural ceramics, with total sales reaching CN¥1.40 billion. Guangdong Orient Zirconic, a nimble player in the chemical sector, has seen its debt to equity ratio improve significantly from 129% to 39% over five years. Trading at nearly 90% below estimated fair value, it seems undervalued by market standards. Despite recent volatility in its share price, the company turned profitable this year and boasts high-quality earnings. The net debt to equity ratio stands at a satisfactory 10%, indicating prudent financial management. Recent amendments to its articles of association suggest strategic shifts that may influence future operations positively or negatively depending on execution and market conditions. Take a closer look at Guangdong Orient Zirconic Ind Sci & TechLtd's potential here in our health report. Evaluate Guangdong Orient Zirconic Ind Sci & TechLtd's historical performance by accessing our past performance report. Yangzhou Seashine New MaterialsLtd Simply Wall St Value Rating: ★★★★★★ Overview: Yangzhou Seashine New Materials Co., Ltd. specializes in the design, production, and marketing of powder metallurgy structural parts in China with a market cap of CN¥4.62 billion. Operations: Yangzhou Seashine generates revenue primarily from the sale of powder metallurgy structural parts. The company's financial performance is impacted by its cost structure, which includes expenses related to production and marketing. Yangzhou Seashine New Materials, a small player in the Asian market, has shown impressive performance with earnings growth of 33.6% over the past year, outpacing its industry peers. Despite a volatile share price recently, this company remains debt-free for five years and boasts high-quality earnings. Its free cash flow turned positive at CNY 70.54 million by the end of 2024, reflecting efficient capital management with capital expenditure dropping to CNY 9.01 million. Revenue is projected to grow annually by 21.43%, indicating promising future prospects amidst recent dividend increases for shareholders in June 2025. Click to explore a detailed breakdown of our findings in Yangzhou Seashine New MaterialsLtd's health report. Gain insights into Yangzhou Seashine New MaterialsLtd's historical performance by reviewing our past performance report. Where To Now? Dive into all 2605 of the Asian Undiscovered Gems With Strong Fundamentals we have identified here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:9966 SZSE:002167 and SZSE:300885. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
